EDITORIAL: Moving Beyond the Diagnosis of Vestibulodynia—A Holiday Wish List
References
- 1 Bouchard C, Brisson J, Fortier M, Morin C, Blanchette C. Use of oral contraceptive pills and vulvar vestibulitis: A case-control study. Am J Epidemiol 2002; 156: 254–61.
- 2 Foster DC, Sazenski TM, Stodgell CJ. Impact of genetic variation in interleukin-1 receptor antagonist and melanocortin-1 receptor genes on vulvar vestibulitis syndrome. J Reprod Med 2004; 49: 503–9.
- 3 Babula O, Danielsson I, Sjoberg I, Ledger WJ, Witkin SS. Altered distribution of mannose-binding lectin alleles at exon I codon 54 in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2004; 191: 762–6.
- 4 Gerber S, Bongiovanni AM, Ledger WJ, Witkin SS. Interleukin-1 beta gene polymorphism in women with vulvar vestibulitis syndrome. Eur J Obstet Gynecol Reprod Biol 2003; 107: 74–7.
- 5 Plante AF, Kamm MA. Life events in patients with vulvodynia. BJOG 2008; 115: 509–14.
- 6 Harlow BL, Stewart EG. Adult-onset vulvodynia in relation to childhood violence victimization. Am J Epidemiol 2005; 161: 871–80.
- 7 Reed BD, Haefner HK, Punch MR, Roth RS, Gorenflo DW, Gillespie BW. Psychosocial and sexual functioning in women with vulvodynia and chronic pelvic pain. A comparative evaluation. J Reprod Med 2000; 45: 624–32.
- 8 Burrows LJ, Klingman D, Pukall CF, Goldstein AT. Umbilical hypersensitivity in women with primary vestibulodynia. J Reprod Med 2008; 53: 413–6.
- 9 Bornstein J, Cohen Y, Zarfati D, Sela S, Ophir E. Involvement of heparanase in the pathogenesis of localized vulvodynia. Int J Gynecol Pathol 2008; 27: 136–41.
- 10 Bornstein J, Goldschmid N, Sabo E. Hyperinnervation and mast cell activation may be used as histopathologic diagnostic criteria for vulvar vestibulitis. Gynecol Obstet Invest 2004; 58: 171–8.
- 11 Bohm-Starke N, Hilliges M, Falconer C, Rylander E. Increased intraepithelial innervation in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest 1998; 46: 256–60.
- 12 Eva LJ, MacLean AB, Reid WM, Rolfe KJ, Perrett CW. Estrogen receptor expression in vulvar vestibulitis syndrome. Am J Obstet Gynecol 2003; 189: 458–61.
- 13
Goldstein AT,
Pukall C,
Goldstein I (eds.) Sexual pain disorders: Evaluation and management. Hoboken, NJ: Wiley-Blackwell; 2009.
10.1002/9781444308136 Google Scholar
- 14 Pukall CF, Strigo IA, Binik YM, Amsel R, Khalife S, Bushnell MC. Neural correlates of painful genital touch in women with vulvar vestibulitis syndrome. Pain 2005; 115: 118–27.
- 15 Foster DC, Piekarz KH, Murant TI, LaPoint R, Haidaris CG, Phipps RP. Enhanced synthesis of proinflammatory cytokines by vulvar vestibular fibroblasts: Implications for vulvar vestibulitis. Am J Obstet Gynecol 2007; 196: e1–8.
- 16 Halperin R, Zehavi S, Vaknin Z, Ben-Ami I, Pansky M, Schneider D. The major histopathologic characteristics in the vulvar vestibulitis syndrome. Gynecol Obstet Invest 2005; 59: 75–9.
- 17 Rosenbaum TY, Owens A. The role of pelvic floor physical therapy in the treatment of pelvic and genital pain-related sexual dysfunction (CME). J Sex Med 2008; 5: 513–23; quiz 24–5.
- 18 Goldstein AT, Burrows L. Vulvodynia. J Sex Med 2008; 5: 5–14; quiz 5.
- 19 Edwards L. New concepts in vulvodynia. Am J Obstet Gynecol 2003; 189(3 suppl): S24–30.
- 20 Friedrich EG Jr. Vulvar vestibulitis syndrome. J Reprod Med 1987; 32: 110–4.
- 21 Boardman LA, Cooper AS, Blais LR, Raker CA. Topical gabapentin in the treatment of localized and generalized vulvodynia. Obstet Gynecol 2008; 112: 579–85.
- 22 Bradford A, Meston C. Correlates of placebo response in the treatment of sexual dysfunction in women: A preliminary report. J Sex Med 2007; 4: 1345–51.
